Riverhead Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$354K Sell
1,300
-150
-10% -$41.7K 0.01% 882
2019
Q2
$399K Sell
1,450
-916
-39% -$226K 0.01% 823
2019
Q1
$529K Buy
2,366
+153
+7% +$31.6K 0.02% 686
2018
Q4
$412K Buy
2,213
+555
+33% +$114K 0.02% 725
2018
Q3
$414K Sell
1,658
-110
-6% -$26.7K 0.02% 850
2018
Q2
$385K Sell
1,768
-194
-10% -$40K 0.02% 781
2018
Q1
$375K Sell
1,962
-887
-31% -$164K 0.02% 775
2017
Q4
$445K Sell
2,849
-2,321
-45% -$365K 0.02% 710
2017
Q3
$804K Buy
5,170
+310
+6% +$49K 0.04% 464
2017
Q2
$785K Buy
4,860
+2,080
+75% +$338K 0.04% 450
2017
Q1
$430K Buy
2,780
+610
+28% +$84.1K 0.02% 574
2016
Q4
$254K Buy
2,170
+200
+10% +$22.8K 0.02% 667
2016
Q3
$222K Sell
1,970
-1,396
-41% -$147K 0.01% 663
2016
Q2
$23K Sell
3,366
-12,209
-78% -$1.05M ﹤0.01% 1396
2016
Q1
$1.22M Sell
15,575
-2,225
-13% -$160K 0.02% 631
2015
Q4
$1.3M Buy
17,800
+13,100
+279% +$934K 0.02% 616
2015
Q3
$349K Buy
+4,700
New +$337K 0.01% 602

Other funds holding IDXX

Riverhead Capital Management's IDXX Position: Q3 2019 in Review

Riverhead Capital Management reduced its Idexx Laboratories (IDXX) stake by 10% in Q3 2019, selling an estimated $41.7K and leaving 1,300 shares worth $354K. The position accounts for 0.01% of the portfolio, ranked #882.

Riverhead Capital Management first reported a position in IDXX in Q3 2015 and has held it in 17 quarters since. The position peaked at $1.3M in Q4 2015. 720 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.

  • Riverhead Capital Management held 1,300 shares of Idexx Laboratories worth $354K as of Q3 2019.
  • Riverhead Capital Management sold 150 Idexx Laboratories shares in Q3 2019, an estimated $41.7K.
  • Idexx Laboratories made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #882 holding.
  • Riverhead Capital Management first reported a position in Idexx Laboratories in Q3 2015 and has held it in 17 quarters since.
  • Riverhead Capital Management's Idexx Laboratories position peaked at $1.3M in Q4 2015.
  • 720 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.